Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Brain Research|November 7, 2002
Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptorsJ N Joyce, H L Ryoo, T B Beach, et al.
Clinical Neuropharmacology|May 10, 2000
A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesiaR A Hauser, J Friedlander, T A Zesiewicz, et al.
Parkinsonism & Related Disorders|June 1, 2002
Motor unit number estimates in idiopathic Parkinson's diseaseJ N Caviness, B E Smith, J Clarke Stevens, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Motor unit changes in sporadic idiopathic Parkinson's diseaseJ N Caviness, B E Smith, J C Stevens, et al.
Archives of Neurology|August 26, 1998
Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group IIIC H Adler, C Singer, C O'Brien, et al.
Neurology|June 3, 2011
Quantitative EEG as a predictive biomarker for Parkinson disease dementiaB T Klassen, J G Hentz, H A Shill, et al.
Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.
Archives of Neurology|September 18, 1998
Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study GroupK D Sethi, C F O'Brien, J P Hammerstad, et al.
Parkinsonism & Related Disorders|March 10, 2007
Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's diseaseJ N Caviness, J G Hentz, V G Evidente, et al.
Pageof 7